According to the Hong Kong Cancer Registry, most of the increase in new cancer cases in Hong Kong is due to an increase in cancers found almost exclusively in women such as those affecting the breast, corpus uteri, ovary and thyroid, and in both genders, colorectal cancer. 1 Although more men (15,101) were diagnosed with cancer than women (14,517) in 2014, the male-tofemale ratio of 1.04:1 was a sharp decrease from 1.18:1 in 2004. 1 With the prevalent trend in cancer incidences and anticipated population structure, this gender ratio is expected to reverse in the coming years. Indeed, cancer was more common in women than in men in the agegroup of 20 to 60 years, even more so in those aged 20 to 44 years where the number of cancers in women was about double that of men. 1 The Table shows the 10 most common cancers diagnosed in women in Hong Kong in 2014. Both a larger and growing female population within the age-groups, and high incidence of genderspecific cancers of the breast, cervix, corpus uteri and ovary accounted for the female preponderance. The plethora of articles published in the current issue that focuses on various diagnostic imaging studies for breast tumours or lesions, and imaging studies for diagnosing and treating gynaecological cancers of endometrial carcinoma and cervical carcinoma respectively illustrate precisely the magnitude of clinical practice catering for these women.
In 2014, 3868 women were diagnosed with invasive breast cancer, an increase of 9.8% from 2013. 1 Indeed, the number of invasive female breast cancer cases has increased by 70% since 2004. 1 In addition, another 530 cases of ductal carcinoma in situ (DCIS) of breast were recorded.
2 Although a population-based breast cancer screening programme has not been implemented in Hong Kong, opportunistic breast screening or diagnostic imaging for breast lesions and consequent radiologistled diagnostic procedures have become increasingly common due to an increased awareness of breast cancer in the female population.
In recent years, radioguided occult lesion localisation (ROLL) has become a preferred diagnostic procedure for non-palpable and sonographically occult lesions with Cancers of the corpus uteri and ovary have shown a marked increase in number of new cases in 2014 compared with 2013 by 5.8% to almost 1000 cases, and by 9.5% to 576 cases in 2014.
1 Surgery remains the mainstay primary treatment for endometrial cancers after which additional adjuvant therapies such as radiotherapy or chemotherapy will be guided by information about the pathological staging. This comprises depth of myometrial invasion, cervical stromal involvement, histological evidence of lymph node metastasis, and adnexal and peritoneal metastasis. In patients who are not surgical candidates because of medical co-morbidities or who are considering fertility-sparing treatment, magnetic resonance imaging (MRI) with or without positron emission tomography / computed tomography (CT) is considered the best surrogate staging procedure short of surgical staging. 7 Chan et al 8 confirmed that MRI could predict pathological staging of endometrial cancers with >80% accuracy in a local cohort of 90 patients. Although there is still room for improving the sensitivity in detecting cervical stromal invasion and pelvic lymph node metastasis, the staging information will provide very relevant guidance to clinical oncologists when formulating the most appropriate non-surgical treatment for such patients who are not undergoing primary surgery.
Although the number of cervical cancers dropped by 6.2% to a total of 472 cases in 2014, the recent introduction of image-guided brachytherapy (IGBT) for cervical cancers has gradually rekindled the interest of clinical oncologists in further improving the treatment algorithms for this once prevalent female cancer. 1, 9 Interstitial brachytherapy, a three-dimensional brachytherapy treatment technique, has revolutionised the dosimetry system of how brachytherapy should be practised, prescribed and evaluated. 9 The smooth implementation of this newly acquired technique definitely calls for concerted contributions from diagnostic radiology colleagues of the multidisciplinary gynaecological oncology team in different institutions. As shown by Siu et al, 10 it becomes mandatory to replace the gold standard Manchester point A and International Commission on Radiation Units and Measurements (ICRU) rectal point as reference points to measure tumour and rectal doses respectively by new reference dose volumes (D90 of high-risk clinical target volume, and rectal D2cc) during this inevitable paradigm shift. In their report of 34 patients with cervical cancers imaged by CT rather than MRI scans for computing IGBT dosimetry, correlation of IGBT dose volumes with ICRU point doses were inconsistent.
Last but not least, retrospective results of uterine artery embolisation (UAE) reported by both Lam and Lo 11 and Wong et al 12 in treating pregnancy-related complications and symptomatic fibroids in their institutions respectively confirmed not only high rates of technical success and clinical efficacy, but also a favourable safety profile, providing evidence that UAE is a promising non-surgical therapy for patients with such clinical indications. The pictorial essay by Tsang et al 13 describes the various MRI features of complications arising from breast augmentation. These definitely complement the findings of the initial radiological workup of patients suspected of having such complications and who might need corrective surgery.
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We hope the broad array of articles published in this themed issue of the Journal focusing on 'Women's Imaging and Oncology' will help clinicians, radiologists, and oncologists alike to reflect and prepare themselves to better manage the increasing number of women suffering from female cancers.
